Barbara Wiggins to Humans
This is a "connection" page, showing publications Barbara Wiggins has written about Humans.
Connection Strength
0.516
-
Select drug-drug interactions with colchicine and cardiovascular medications: A review. Am Heart J. 2022 10; 252:42-50.
Score: 0.031
-
Statin-associated muscle symptoms-A review: Individualizing the approach to optimize care. Pharmacotherapy. 2022 05; 42(5):428-438.
Score: 0.031
-
Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia. J Cardiovasc Pharmacol. 2021 11 01; 78(5):e631-e640.
Score: 0.030
-
Effectiveness and Safety of Direct Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation and Weighing = 120 Kilograms versus 60-120 Kilograms. Am J Cardiovasc Drugs. 2021 Sep; 21(5):545-551.
Score: 0.029
-
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2020 08 04; 76(5):594-622.
Score: 0.027
-
Select Drug-Drug Interactions With Direct?Oral Anticoagulants: JACC Review Topic of the Week. J Am Coll Cardiol. 2020 03 24; 75(11):1341-1350.
Score: 0.027
-
Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update. J Pharm Pract. 2020 Dec; 33(6):882-894.
Score: 0.026
-
2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018 12 25; 72(25):3332-3365.
Score: 0.025
-
2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 2: Radiological Equipment Operation, Dose-Sparing Methodologies, Patient and Medical Personnel Protection. Catheter Cardiovasc Interv. 2018 08 01; 92(2):222-246.
Score: 0.024
-
2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging-Best Practices for Safety and Effectiveness, Part 1: Radiation Physics and Radiation Biology: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways Developed in Collaboration With Mended Hearts. Catheter Cardiovasc Interv. 2018 08 01; 92(2):203-221.
Score: 0.024
-
2018 ACC/HRS/NASCI/SCAI/SCCT Expert Consensus Document on Optimal Use of Ionizing Radiation in Cardiovascular Imaging: Best Practices for Safety and Effectiveness. Catheter Cardiovasc Interv. 2018 08 01; 92(2):E35-E97.
Score: 0.024
-
Evolocumab: Considerations for the Management of Hyperlipidemia. Curr Atheroscler Rep. 2018 03 06; 20(4):17.
Score: 0.023
-
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol. 2017 Dec 19; 70(24):3042-3067.
Score: 0.023
-
Recommendations for Managing Drug-Drug Interactions with Statins and HIV Medications. Am J Cardiovasc Drugs. 2017 Oct; 17(5):375-389.
Score: 0.023
-
Higher Maximum Doses and Infusion Rates Compared with Standard Unfractionated Heparin Therapy Are Associated with Adequate Anticoagulation without Increased Bleeding in Both Obese and Nonobese Patients with Cardiovascular Indications. Pharmacotherapy. 2017 Apr; 37(4):393-400.
Score: 0.022
-
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2016 11 22; 134(21):e468-e495.
Score: 0.021
-
Gemfibrozil in Combination with Statins-Is It Really Contraindicated? Curr Atheroscler Rep. 2016 Apr; 18(4):18.
Score: 0.020
-
Reduced Anticoagulant Effect of Dabigatran in a Patient Receiving Concomitant Phenytoin. Pharmacotherapy. 2016 Feb; 36(2):e5-7.
Score: 0.020
-
Discharge counseling for patients with heart failure or myocardial infarction: a best practices model developed by members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network based on the Hospital to Home (H2H) Initiative. Pharmacotherapy. 2013 May; 33(5):558-80.
Score: 0.017
-
Key articles and guidelines in the management of acute coronary syndromes and in percutaneous coronary intervention: 2007 update. Pharmacotherapy. 2007 Dec; 27(12):1722-58.
Score: 0.011
-
Bivalirudin: a direct thrombin inhibitor for percutaneous transluminal coronary angioplasty. Pharmacotherapy. 2002 Aug; 22(8):1007-18.
Score: 0.008
-
A Response to: Letter to the Editor Regarding "Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: a Narrative Review". Adv Ther. 2020 09; 37(9):4046-4048.
Score: 0.007
-
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review. Adv Ther. 2020 02; 37(2):656-670.
Score: 0.007
-
High-impact articles related to the management of heart failure: 2008 update. Pharmacotherapy. 2009 Jan; 29(1):82-120.
Score: 0.003
-
Intraosseous drug administration in children and adults during cardiopulmonary resuscitation. Ann Pharmacother. 2007 Oct; 41(10):1679-86.
Score: 0.003
-
Pharmacotherapy considerations in advanced cardiac life support. Pharmacotherapy. 2006 Dec; 26(12):1703-29.
Score: 0.003
-
Newer pharmacotherapy in patients undergoing percutaneous coronary interventions: a guide for pharmacists and other health care professionals. Pharmacotherapy. 2006 Nov; 26(11):1537-56.
Score: 0.003
-
Role of P-glycoprotein in statin drug interactions. Pharmacotherapy. 2006 Nov; 26(11):1601-7.
Score: 0.003
-
High-impact articles related to the pharmacotherapeutic management of systolic heart failure. Pharmacotherapy. 2004 Nov; 24(11):1594-633.
Score: 0.002